IPX — Iperionx Income Statement
0.000.00%
Last trade - 00:00- AU$2.49bn
- AU$2.41bn
- 23
- 23
- 91
- 42
Annual income statement for Iperionx, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.005 | 0.401 | 0.494 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.2 | 21.9 | 17.9 | 22.2 | 38.3 |
| Operating Profit | -13.2 | -21.5 | -17.4 | -22.2 | -38.3 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.2 | -21.5 | -17.4 | -21.8 | -35.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.2 | -21.5 | -17.4 | -21.8 | -35.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.2 | -21.5 | -17.4 | -21.8 | -35.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.2 | -21.5 | -17.4 | -21.8 | -35.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.134 | -0.16 | -0.104 | -0.099 | -0.118 |
| Dividends per Share |